Strive Health improves key KPIs with homegrown machine learning
The kidney care provider’s build-not-buy effort has shown great results: 30-day readmissions are down 36%, hospitalizations among high-risk patients are down 49% and optimal starts are up 67%.
The kidney care provider’s build-not-buy effort has shown great results: 30-day readmissions are down 36%, hospitalizations among high-risk patients are down 49% and optimal starts are up 67%.
Go to Source
2025-04-03 21:17
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
